Ideas to action: independent research for global prosperity
Search
Filters:
Experts
Facet Toggle
Topics
Facet Toggle
Content Type
Facet Toggle
Publication Type
Facet Toggle
Article Type
Facet Toggle
Time Frame
Facet Toggle
Feb
13
2020
9:00—11:00 AM ET
February 07, 2020
The outbreak of the novel Coronavirus, known as 2019-nCoV, is growing by the day, and increasingly posing risks beyond China—with the developing world particularly at risk. Combining high transmissibility, a concerning fatality rate, and no medical countermeasures, experts warn the disease is evolvi...
Feb
10
2020
10:00—11:30 AM
January 31, 2020
Spending on pharmaceuticals and other health care commodities is one of the fastest growing elements of healthcare spending in rich and poorer countries alike. A popular response to the problem of escalating drugs budgets has been seeking transparency of drug pricing within and across borders. In a ...
Blog Post
January 15, 2020
Poor quality medicines pose significant risks to global health. This blog responds to a recent report from the National Academies that out clear recommendations to global, national and agency level stakeholders which can help strengthen food and medical products regulatory systems in low- and middle...
CGD NOTES
December 12, 2019
New technology, better use of data, and entrepreneurial passion in improving distribution channels is reaching a critical mass with the potential to drive extraordinary improvements in availability, affordability, and quality of health products. Global health institutions can play a significant role...
POLICY PAPERS
March 04, 2015
Donors play a significant role in funding medicines and other commodities in global health. Of the approximately US $28.2 billion spent by donors in 2010, approximately 40% went towards medicines, vaccines and other health commodities, mainly in sub-Saharan Africa. The efficiency of this spend is th...